HLN
NEUTRALHaleon Directors Increase Shareholdings
The healthcare company Haleon has announced that two of its senior executives have acquired additional shares in the business.
Haleon
360.30GBX
1.15%
Market Cap
32.09B
Volume
3.68M
17% of avg
P/E Ratio
1771.65
EPS (TTM)
0.2
Beta
0.23
Day Range
355.00p - 360.40p
52 Week Range
274.40p360.30p419.50p
360.30p
Upcoming Events
HLN
NEUTRALHaleon Announces Director/PDMR Shareholding
The consumer healthcare company has disclosed changes to director and PDMR shareholdings.
HLN
NEUTRALHaleon Appoints Vindi Banga as New Chair
The consumer healthcare company has announced the resignation of its current Chair, Sir Dave Lewis, and the appointment of Vindi Banga as the new Chair effective January 1, 2026.
HLN
NEUTRALHaleon's Q3 Trading Update Meets Expectations
The consumer healthcare company's Q3 trading update meets market expectations, with no major surprises reported.
HLN
NEUTRALHaleon Announces Director/PDMR Shareholding
The consumer healthcare company has announced changes to its director and PDMR shareholdings.
HLN
NEUTRALHaleon Announces Director Appointment
The healthcare company has announced the appointment of a new Non-Executive Director to its board.
HLN
NEUTRALHaleon Announces Director/PDMR Shareholding Changes
The consumer healthcare company Haleon has announced changes to the shareholdings of its directors and other persons discharging managerial responsibilities.
HLN
NEUTRALHaleon Announces Change in Major Shareholder
The healthcare company reports a change in major shareholder, with Wellington Management Group LLP increasing its stake.
HLN
NEUTRALHaleon Announces Director/PDMR Shareholding
The consumer healthcare company has disclosed changes to director and PDMR shareholdings through dividend reinvestment.
HLN
NEUTRALHaleon Announces Director/PDMR Shareholding
The consumer healthcare company has announced changes to its director and PDMR shareholdings.